Biological Compatibility

There’s a lot of buzz right now around formulations that pair biologicals with synthetic actives—and it makes sense. Biologicals offer enormous sustainable upside (new modes of action and plant–microbe interactions), but they often struggle with field-to-field consistency. Synthetics, while carrying their own environmental and regulatory risks, are typically far more predictable and robust. The pairing is attractive because it can (1) help address rising pest resistance to synthetics, (2) improve ROI through complementary performance and reduced passes, and (3) “stacking” mechanisms to better tackle complex, multi-factor problems.

From a formulation perspective, the hard part is compatibility. Biologicals may be spore-forming to maximize shelf life, while non-spore-formers are often down processed into dry, quiescent formats to preserve viability. In liquids, accidental “wake-up” and subsequent decline is a real risk—so low water activity and (when the use-case allows) oil-dispersible strategies can be helpful. Synthetics don’t share those viability constraints, but many require specific solvents or surfactant systems to solubilize water-insoluble actives. Those same additives can disrupt microbial membranes or reduce viability. And if you’re working in aqueous systems, even seemingly standard tools like in-can preservatives become complicated because they can harm the very biology you’re trying to deliver. Bottom line: an “all-in-one” bio + synthetic product isn’t just a marketing idea—it’s a disciplined compatibility and stability problem spanning formulation, storage, and application.

This is exactly where my experience fits.

At Indigo Ag, I built and scaled the on-seed compatibility and stewardship program that supported Indigo’s biotrinsic® positioning across corn, soybean, wheat, and cotton. Working closely with agronomy, we identified the most common seed-applied pesticide packages by crop and co-applied them with Indigo’s endophyte library, tracking on-seed survivability and treat-to-plant windows. I also expanded evaluation beyond the seed by creating a soil mesocosm assay to test how seed-delivered microbes perform alongside starter fertilizers and in-furrow pesticides, translating results into practical deployment recommendations.

At Pivot Bio, I served as technical project manager for PROVEN® 40 On-Seed and led Application Research, bridging R&D to commercial execution. I developed the extender (liquid carrier) strategy to reliably deliver nitrogen-fixing microbes to pre-treated seed, improving on-seed stability and enabling commercial practicality. I also partnered with treater OEMs and seed treaters to validate equipment workflows, mixing protocols, and seed flowability practices that preserved microbial viability through real-world operations. In parallel, I helped build the data infrastructure needed to learn quickly at scale—capturing seed metadata and correlating treat/plant titers to field outcomes to guide release decisions and stewardship. Ultimately, through these efforts we extended shelf-life to meet treat-to-plant windows, we ensured equipment compatibility, and supported a scale out from 10K initially trialed acres out to a 1M+ acre launch in year three of development.

Now, through BioAg Insights LLC, my goal is to bring this industry-backed, execution-tested experience to teams building the next wave of crop solutions. If you’re tackling bio + synthetic compatibility, need help designing fit-for-purpose formulation and stability screens, building lab and controlled-environment workflows, translating results into treat-to-plant stewardship, or validating field deployment without disrupting grower operations—I’d love to help.